The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Brain Tumor Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
A brain tumor occurs when abnormal cells form within the brain.
The global Brain Tumor Therapeutics market size is expected to reach US$ 2298.4 million by 2029, growing at a CAGR of 10.4% from 2023 to 2029. The market is mainly driven by the significant applications of Brain Tumor Therapeutics in various end use industries. The expanding demands from the Hospitals, Oncology Treatment Centers and Others,, are propelling Brain Tumor Therapeutics market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing geriatric population.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brain Tumor Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brain Tumor Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brain Tumor Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brain Tumor Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brain Tumor Therapeutics covered in this report include Pfizer, Novartis, Roche, Merck, AstraZeneca, GE Healthcare, Hitachi Medical, Philips Healthcare and Novocure, etc.
The global Brain Tumor Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals
Global Brain Tumor Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brain Tumor Therapeutics market, Segment by Type:
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy
Global Brain Tumor Therapeutics market, by Application
Hospitals
Oncology Treatment Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brain Tumor Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A brain tumor occurs when abnormal cells form within the brain.
The global Brain Tumor Therapeutics market size is expected to reach US$ 2298.4 million by 2029, growing at a CAGR of 10.4% from 2023 to 2029. The market is mainly driven by the significant applications of Brain Tumor Therapeutics in various end use industries. The expanding demands from the Hospitals, Oncology Treatment Centers and Others,, are propelling Brain Tumor Therapeutics market. Surgery, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing geriatric population.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Brain Tumor Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Brain Tumor Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Brain Tumor Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Brain Tumor Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Brain Tumor Therapeutics covered in this report include Pfizer, Novartis, Roche, Merck, AstraZeneca, GE Healthcare, Hitachi Medical, Philips Healthcare and Novocure, etc.
The global Brain Tumor Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
Roche
Merck
AstraZeneca
GE Healthcare
Hitachi Medical
Philips Healthcare
Novocure
DelMar Pharmaceuticals
Global Brain Tumor Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Brain Tumor Therapeutics market, Segment by Type:
Surgery
Radiation Therapy
Targeted Therapy
Chemotherapy
Immunotherapy
Global Brain Tumor Therapeutics market, by Application
Hospitals
Oncology Treatment Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Brain Tumor Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Brain Tumor Therapeutics
1.1 Brain Tumor Therapeutics Market Overview
1.1.1 Brain Tumor Therapeutics Product Scope
1.1.2 Brain Tumor Therapeutics Market Status and Outlook
1.2 Global Brain Tumor Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Brain Tumor Therapeutics Market Size by Region (2018-2029)
1.4 Global Brain Tumor Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Brain Tumor Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Brain Tumor Therapeutics Market Size (2018-2029)
1.6.1 North America Brain Tumor Therapeutics Market Size (2018-2029)
1.6.2 Europe Brain Tumor Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Brain Tumor Therapeutics Market Size (2018-2029)
1.6.4 Latin America Brain Tumor Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Brain Tumor Therapeutics Market Size (2018-2029)
2 Brain Tumor Therapeutics Market by Type
2.1 Introduction
2.1.1 Surgery
2.1.2 Radiation Therapy
2.1.3 Targeted Therapy
2.1.4 Chemotherapy
2.1.5 Immunotherapy
2.2 Global Brain Tumor Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Brain Tumor Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Brain Tumor Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Brain Tumor Therapeutics Revenue Breakdown by Type (2018-2029)
3 Brain Tumor Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Oncology Treatment Centers
3.1.3 Others
3.2 Global Brain Tumor Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Brain Tumor Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Brain Tumor Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Brain Tumor Therapeutics Revenue Breakdown by Application (2018-2029)
4 Brain Tumor Therapeutics Competition Analysis by Players
4.1 Global Brain Tumor Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brain Tumor Therapeutics as of 2022)
4.3 Date of Key Players Enter into Brain Tumor Therapeutics Market
4.4 Global Top Players Brain Tumor Therapeutics Headquarters and Area Served
4.5 Key Players Brain Tumor Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Brain Tumor Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Brain Tumor Therapeutics Products, Services and Solutions
5.1.4 Pfizer Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Novartis
5.2.1 Novartis Profile
5.2.2 Novartis Main Business
5.2.3 Novartis Brain Tumor Therapeutics Products, Services and Solutions
5.2.4 Novartis Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Novartis Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Brain Tumor Therapeutics Products, Services and Solutions
5.3.4 Roche Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Recent Developments
5.4 Merck
5.4.1 Merck Profile
5.4.2 Merck Main Business
5.4.3 Merck Brain Tumor Therapeutics Products, Services and Solutions
5.4.4 Merck Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Recent Developments
5.5 AstraZeneca
5.5.1 AstraZeneca Profile
5.5.2 AstraZeneca Main Business
5.5.3 AstraZeneca Brain Tumor Therapeutics Products, Services and Solutions
5.5.4 AstraZeneca Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 AstraZeneca Recent Developments
5.6 GE Healthcare
5.6.1 GE Healthcare Profile
5.6.2 GE Healthcare Main Business
5.6.3 GE Healthcare Brain Tumor Therapeutics Products, Services and Solutions
5.6.4 GE Healthcare Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 GE Healthcare Recent Developments
5.7 Hitachi Medical
5.7.1 Hitachi Medical Profile
5.7.2 Hitachi Medical Main Business
5.7.3 Hitachi Medical Brain Tumor Therapeutics Products, Services and Solutions
5.7.4 Hitachi Medical Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Hitachi Medical Recent Developments
5.8 Philips Healthcare
5.8.1 Philips Healthcare Profile
5.8.2 Philips Healthcare Main Business
5.8.3 Philips Healthcare Brain Tumor Therapeutics Products, Services and Solutions
5.8.4 Philips Healthcare Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Philips Healthcare Recent Developments
5.9 Novocure
5.9.1 Novocure Profile
5.9.2 Novocure Main Business
5.9.3 Novocure Brain Tumor Therapeutics Products, Services and Solutions
5.9.4 Novocure Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Novocure Recent Developments
5.10 DelMar Pharmaceuticals
5.10.1 DelMar Pharmaceuticals Profile
5.10.2 DelMar Pharmaceuticals Main Business
5.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Products, Services and Solutions
5.10.4 DelMar Pharmaceuticals Brain Tumor Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 DelMar Pharmaceuticals Recent Developments
6 North America
6.1 North America Brain Tumor Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Brain Tumor Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Brain Tumor Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Brain Tumor Therapeutics Market Dynamics
11.1 Brain Tumor Therapeutics Industry Trends
11.2 Brain Tumor Therapeutics Market Drivers
11.3 Brain Tumor Therapeutics Market Challenges
11.4 Brain Tumor Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
